Marksans Pharma strengthens European presence with €7.5 million QliniQ acquisition - CNBC TV18
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Salt Creek has acquired MML Diagnostics Packaging, a medical devices business in New York, for an undisclosed amount. Salt Creek acquisitions in healthcare M&A focus on expanding capabilities in medical devices, with MML Diagnostics Packaging supporting diagnostic and packaging needs for device workflows. The add on acquisition strengthens Salt Creek’s footprint in NY acquisitions and supports growth in healthcare deals NY. The medical devices acquisition is structured as an add on acquisition under private equity acquisition strategy, with Geoffrey Pestes promoted to CEO following the deal announcement.
Filed under
Powered by Tentt
Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Marksans Pharma→QliniQ
Jun 1, 2026
Frazier Healthcare Partners→Altruix
May 31, 2026
Signos
May 31, 2026
Sterling Bay→Pacific Center
May 29, 2026